Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart
disease, with complex phenotypic and genetic expression and natural history, affecting both …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline
provides recommendations and algorithms for clinicians to diagnose and manage …

Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A
variety of mostly hereditary, structural, or electrical cardiac disorders are associated with …

Background Patients with nonobstructive hypertrophic cardiomyopathy (nHCM) often
experience a high burden of symptoms; however, there are no proven pharmacological …

Background: Cardiomyopathies are a heterogeneous group of pathologies characterized by
structural and functional alterations of the heart. Aims: The purpose of this narrative review is …

Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …

Hypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which
prevalence in the general population has not been completely resolved. For the past 20 …

Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A
variety of mostly hereditary, structural or electrical cardiac disorders are associated with …

Background—Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden
death in the young, although not all patients eligible for sudden death prevention with an …